PHADECODE XA INHIBITOR ASSAY

Antithrombin Iii Quantitation

PHARMASEAL DIV., BAXTER HEALTHCARE CORP.

The following data is part of a premarket notification filed by Pharmaseal Div., Baxter Healthcare Corp. with the FDA for Phadecode Xa Inhibitor Assay.

Pre-market Notification Details

Device IDK792019
510k NumberK792019
Device Name:PHADECODE XA INHIBITOR ASSAY
ClassificationAntithrombin Iii Quantitation
Applicant PHARMASEAL DIV., BAXTER HEALTHCARE CORP. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeJBQ  
CFR Regulation Number864.7060 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1979-10-09
Decision Date1979-11-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.